milnacipran has been researched along with Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altamirano, A; Gandhi, SJ; Williams, GW | 1 |
| Boerstoel-Streefland, M; Duh, MS; Guérin, A; Jiang, W; Lefebvre, P; Mease, PJ; Vekeman, F; Zimetbaum, PJ | 1 |
| Chou, SY; Hung, TH; Su, JA; Tsai, CS; Tsang, HY; Wu, CL | 1 |
| Bogolepova, AN; Gekht, AB; Gudkova, AA; Sorokina, IB | 1 |
| Asada, T; Ohta, H; Satoh, S; Sawa, S; Yamakawa, Y | 1 |
| Asada, T; Ohta, H; Sato, S; Terashima, Y; Yamakawa, Y | 1 |
| Endo, S; Imai, R; Isayama, K; Kanetani, K; Kimura, M; Suzuki, H | 1 |
4 trial(s) available for milnacipran and Stroke
| Article | Year |
|---|---|
Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial.
Topics: Aged; Cyclopropanes; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Milnacipran; Stroke; Treatment Outcome | 2011 |
Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
Topics: Activities of Daily Living; Affect; Aged; Antidepressive Agents; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Quality of Life; Stroke; Stroke Rehabilitation; Surveys and Questionnaires; Treatment Outcome | 2005 |
Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Cyclopropanes; Depressive Disorder; Depressive Disorder, Major; Female; Functional Laterality; Humans; Male; Middle Aged; Milnacipran; Mood Disorders; Psychiatric Status Rating Scales; Stroke; Tomography, X-Ray Computed | 2006 |
Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stroke; Treatment Outcome | 2002 |
3 other study(ies) available for milnacipran and Stroke
| Article | Year |
|---|---|
An acute neurological syndrome with cerebrovascular and parkinsonian clinical features associated with perioperative SNRI withdrawal.
Topics: Adrenergic Uptake Inhibitors; Adult; Cerebrovascular Disorders; Cyclopropanes; Diskectomy; Fibromyalgia; Humans; Male; Milnacipran; Parkinsonian Disorders; Perioperative Period; Selective Serotonin Reuptake Inhibitors; Spinal Fusion; Stroke; Substance Withdrawal Syndrome | 2013 |
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antidepressive Agents; Cardiovascular Diseases; Cyclopropanes; Female; Heart Failure; Humans; Male; Middle Aged; Milnacipran; Myocardial Infarction; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; Stroke; United States; Venlafaxine Hydrochloride | 2011 |
[Experience with ixel (milnacipran hydrochloride) use in the treatment of patients with post-stroke depression].
Topics: Adult; Aged; Antidepressive Agents; Case-Control Studies; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Severity of Illness Index; Stroke; Treatment Outcome | 2003 |